Medizinische Hochschule Hannover (MHH) / Hannover Medical School

University / College

Location: Hannover, Germany (DE)

ISNI: 0000000095299877

ROR: https://ror.org/00f2yqf98

Show on Map:

Publications

(1,554)

Research Grants

(4)

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study (2021) Harbeck N, Rastogi P, Martin M, Tolaney SM, Shao ZM, Fasching P, Huang CS, et al. Journal article Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformatics (2021) Stojanović SD, Fuchs M, Liang C, Schmidt K, Xiao K, Just A, Pfanne A, et al. Journal article Correction to: Transient receptor potential ankyrin 1 promoter methylation and peripheral pain sensitivity in Crohn’s disease (Clinical Epigenetics, (2020), 12, 1, (1), 10.1186/s13148-019-0796-9) (2021) Gombert S, Rhein M, Winterpacht A, Münster T, Hillemacher T, Leffler A, Frieling H Journal article, Erratum German Registry for Cardiac Operations and Interventions in Patients with Congenital Heart Disease: Report 2020-Comprehensive Data from 6 Years of Experience (2021) Beckmann A, Dittrich S, Arenz C, Krogmann ON, Horke A, Tengler A, Meyer R, et al. Journal article Role of endothelial microRNA 155 on capillary leakage in systemic inflammation (2021) Etzrodt V, Idowu TO, Schenk H, Seeliger B, Prasse A, Thamm K, Pape T, et al. Journal article Use and preferences regarding internet-based health care delivery in patients with chronic kidney disease (2021) Schiffer L, Gertges R, Nöhre M, Schieffer E, Tegtbur U, Pape L, de Zwaan M, Schiffer M Journal article Selective retina therapy and thermal stimulation of the retina: different regenerative properties-implications for AMD therapy (2021) Richert E, Papenkort J, Von Der Burchard C, Klettner A, Arnold P, Lucius R, Brinkmann R, et al. Journal article Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia (2021) Rautenberg C, Stoelzel F, Roellig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, et al. Conference contribution Late Non-Relapse Mortality (NRM) after Standard-of-Care (SOC) CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Frequency, Causes, and Risk Factors.a GLA/DRST Real World Analysis (2021) Dreger P, Schubert ML, Holtick U, Subklewe M, Von Bastian T, Ayuk FA, Wagner EM, et al. Conference contribution Standard of Care CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Does Bridging Efficacy Matter? a German GLA/DRST Real World Analysis (2021) Bethge WA, Martus P, Schmitt M, Holtick U, Borchmann P, Subklewe M, Rejeski K, et al. Conference contribution

‹ 1 ... 50 51 52 53 54 ... 156 ›